Regeneron

YTD

ALL

Trade Regeneron 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About REGN

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara.

CEO

Leonard S. Schleifer

CEOLeonard S. Schleifer

Employees

15,410

Employees15,410

Headquarters

Tarrytown, New York

HeadquartersTarrytown, New York

Founded

1988

Founded1988

Employees

15,410

Employees15,410

REGN Key Statistics

Market cap

68.59B

Market cap68.59B

Price-Earnings ratio

15.94

Price-Earnings ratio15.94

Dividend yield

0.56%

Dividend yield0.56%

Average volume

1.20M

Average volume1.20M

High today

$654.94

High today$654.94

Low today

$625.70

Low today$625.70

Open price

$630.52

Open price$630.52

Volume

1.05M

Volume1.05M

52 Week high

$821.11

52 Week high$821.11

52 Week low

$532.60

52 Week low$532.60

Stock Snapshot

The current Regeneron(REGN) stock price is $654.27, with a market capitalization of 68.59B. The stock trades at a price-to-earnings (P/E) ratio of 15.94 and offers a dividend yield of 0.56%.

On 2026-07-03, Regeneron(REGN) stock moved within a range of $625.70 to $654.94. With shares now at $654.27, the stock is trading +4.6% above its intraday low and -0.1% below the session's peak.

Trading activity shows a volume of 1.05M, compared to an average daily volume of 1.2M.

Over the past 52 weeks, Regeneron(REGN) stock has traded between a high of $821.11 and a low of $532.60.

REGN News

Simply Wall St 8h

Regeneron Stock Looks Cheap On Earnings While Its 20% Gain Raises Questions

Regeneron Pharmaceuticals stock has delivered a 20.2% return over the past year, and with a high value score plus an undervalued read on market multiples, the c...

MarketWatch 3d

Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

...

TipRanks 4d

Eli Lilly, Regeneron among first selections for FDA PreCheck program, CNBC says

Eli Lilly (LLY), Regeneron (REGN), Amneal (AMRX), Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will parti...

Analyst ratings

71%

of 31 ratings

Buy

71%

Hold

29%

Sell

More REGN News

CNBC 4d

Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities

Key Points Eli Lilly, Regeneron, Amneal, Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in...

People also own

Based on the portfolios of people who own REGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.